The immune-targeting “stellakines”, which are upregulated in NASH, included CCL2, CCL11, CXCL10, CXCL12, CXCL16, CTGF, and Gas6 (19). This evidence concerns the gene CXCL12 and metabolic dysfunction-associated steatohepatitis.